Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-08-17 | Mr. Cavalier is a seasoned executive and investor with over 20 years of experience in the biotechnology sector. He is being nominated to the Board for the first time. There is no compensation information provided for Mr. Cavalier in the filing. |
| 2019-09-12 | The members of the Audit Committee are Dr. John Monahan (Chairman), Dr. Arnold Baskies and Lewis H. Titterton, Jr. The members of the compensation committee are Lewis H. Titterton, Jr. (Chairman), Dr. Arnold Baskies and Dr. John Monahan. The members of the nominating and corporate governance committee are Dr. Arnold Baskies (Chairman), Dr. John Monahan and Lewis H. Titterton, Jr. Directors' Compensation table shows David Cavalier Total Compensation $202,140. |
| 2020-07-02 | Mr. Cavalier has served on our Board since September 2018. The members of the Audit Committee are David Cavalier (Chairman), Lewis H. Titterton, Jr. and Dr. John Monahan. The following table sets forth compensation of David Cavalier for fiscal year 2019: Total Compensation $144,495. |
| 2021-04-09 | David Cavalier 51 Director 2018 |
Data sourced from SEC filings. Last updated: 2025-08-30